The Valley Desk

NCT04568434 · Interventional trial

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) Administered to Patients With Familial Chylomicronemia Syndrome (FCS)

Overall registry status Completed

Phase 3

Conditions Familial Chylomicronemia Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov